Drawing for XENEREX

USPTO serial 76976622

XENEREX

Reviewed by CopyMark Law Group

Reg. 2882755Status 710
Filing date
Status date
Registration date
Sep 7, 2004
Examiner
MICHOS, JOHN E
Law office
FILE REPOSITORY (FRANCONIA)

What this means

Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.

Status 710: Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active.

Need help with XENEREX?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Salima A. Merani

SALIMA A MERANI2040 MAIN ST 14TH FLIRVINE, CA 92614UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
001Biochemicals, namely, monoclonal antibodies and fragments thereof for research and development, and manufacturing pharmaceuticals; and cell lines for use in the manufacture of pharmaceuticalsSECTION 8 - CANCELLEDMar 2, 2004
042pharmaceutical and biological product development consultation; and pharmaceutical and biological product development for othersSECTION 8 - CANCELLEDAug 15, 2000

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Apr 8, 2011C8..CANCELLED SEC. 8 (6-YR)
Sep 7, 2004R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jun 14, 2004CNPRALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Jun 1, 2004DOCKASSIGNED TO EXAMINER
Apr 2, 2004DOCKASSIGNED TO EXAMINER
Mar 30, 2004SUPCSTATEMENT OF USE PROCESSING COMPLETE
Mar 30, 2004DPCCDIVISIONAL PROCESSING COMPLETE
Mar 18, 2004DRRRDIVISIONAL REQUEST RECEIVED
Mar 18, 2004MAILPAPER RECEIVED
Mar 15, 2004IUAFUSE AMENDMENT FILED
Oct 27, 2003MAILPAPER RECEIVED
Sep 16, 2003NOAMNOA MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Aug 8, 2002TCALTEAS CORR ADDRESS REQUEST RECEIVED BUT NOT PROCESSED LOC IS TTAB
Feb 6, 2002ETOFEXTENSION OF TIME TO OPPOSE RECEIVED
Jan 8, 2002PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Dec 19, 2001NPUBNOTICE OF PUBLICATION
Sep 18, 2001CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER
May 4, 2001CRFACORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 5, 2001UNPRUNRESPONSIVE/DUPLICATE PAPER RECEIVED
Nov 20, 2000CNRTNON-FINAL ACTION MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Nov 9, 2000DOCKASSIGNED TO EXAMINER

Frequently asked questions

Related guidance